Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
DOP056: Long-term outcomes of top-down versus step-up treatment in newly diagnosed Crohns disease: final data
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 7 – Disease & therapy outcome (Keywords: anti-TNF, clinical trials, IBD, immunosuppressive agents, infliximab)
Authors: Daniel Hoekman
DOP056: Pharmacokinetics and Exposure-Response Relationships of Golimumab in Pediatric Patients with Moderate to Severe Ulcerative Colitis: Results from a Multicenter Open Label Study
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 7 - Managing children and adolescents with IBD (Keywords: UC, pharmacokinetics, golimumab, paediatrics, exposure-response)
Authors: Omoniyi Adedokun
DOP057: Evolution of the Lémann Index (LI) during the course of Crohns disease (CD)
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 7 – Disease & therapy outcome (Keywords: CT, disability, disase outcome, IBD, MRI)
Authors: Cyrielle Gilletta
DOP057: Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian registry of paediatric Crohn’s disease (BELCRO)
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 7 - Managing children and adolescents with IBD (Keywords: anti-TNF, biologic treatment, disease outcome, IBD, CD, immunosuppressive agents, pediatric)
Authors: Lucas Wauters
DOP058: Long term avoidance of steroids associated with exclusive enteral nutrition as induction therapy in pediatric crohn’s disease does not increase surgery, hospitalizations or biologics use: results of a propensity score-matched cohort analys
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 7 - Managing children and adolescents with IBD (Keywords: IBD, CD, pediatrics, nutrition)
Authors: Johan Van Limbergen
DOP058: Long-term outcome of infliximab treatment in patients with Crohns disease: a hospital-based cohort study from Korea
Source: Digital Oral Presentation Session 7 – Disease & therapy outcome (Keywords: anti-TNF, infliximab)
Authors: Sang Park
DOP059: Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn’s Disease with Complications or Failure of Medical Treatment
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 7 - Managing children and adolescents with IBD (Keywords: abscess, clinical trials, complications, enterocutaneous fistula, IBD, EEN)
Authors: Xiang Gao
DOP060: Long-term outcome of IBD patients with primary non-response to anti-TNF therapy
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 7 – Disease & therapy outcome
Authors: Konstantinos Papamichail
DOP061: Prospective, observational study of the therapeutic management of mild to moderate Ulcerative Colitis (Observatoire Prospectif, longitudinal dans la prise en charge de la rectocolite hemorragique legere  Moderee, OPTIMUM): Follow-up at 2 years
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 7 – Disease & therapy outcome (Keywords: 5-aminosalicylate, 5-ASA, anti-TNF, AZA, IBD, UC, immunosuppressive agents, mesalamine, 5-aminosalicylic acid, Montreal classification)
Authors: Nadir Mammar
DOP062: Environmental risk factors in paediatric IBD according to the hygiene hypothesis: A case-control study
Source: Presentation - ECCO 2015 Barcelona Congress -Digital Oral Presentation Session 7 – Disease & therapy outcome
Authors: Erasmo Miele
DOP062: Malignancy and mortality in paediatric onset inflammatory bowel disease
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 7 - Managing children and adolescents with IBD (Keywords: cancer , cancer in IBD, IBD, UC, CD, monitoring, mortality)
Authors: M.E. Joosse
DOP063: Measurement of Endoscopic Severity in a Crohn's Disease Multi-Centre Pediatric Inception Cohort: Poor correlation of SES-CD with PCDAI
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 7 - Managing children and adolescents with IBD (Keywords: activity indices, adolescents CRP, disease activity, edoscopic assessment, IBD)
Authors: Nicholas Carman
DOP063: What is stricturing Crohn’s Disease: Comparison of clinical outcome between radiological and endoscopic stricture?
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 7 – Disease & therapy outcome
Authors: Ren Mao
DOP063: What is stricturing Crohn’s Disease: Comparison of clinical outcome between radiological and endoscopic stricture?
Source: Presentation - ECCO 2015 Barcelona Congress -Digital Oral Presentation Session 7 – Disease & therapy outcome
Authors: Ren Mao
DOP064: Predictors of disease relapse of patients with Crohn’s Disease in deep remission: Who and when can withdraw thiopurine maintenance therapy?
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 8 – Predicting remission & relapse
Authors: Ren Mao
DOP064: Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 8 - Pharmacokinetics of IBD therapies (Keywords: adalimumab, anti-TNF, AZA, biologic treatment, IBD, pharmacokinetics)
Authors: Bella Ungar
DOP065: Less anti-infliximab antibody formation in paediatric Crohn's patients on concomitant immunomodulators
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 8 - Pharmacokinetics of IBD therapies (Keywords: anti-TNF, AZA, IBD, immunosuppressive agents, pharmacokinetics)
Authors: Victorien Wolters
DOP065: The predictive factor for relapse of Ulcerative Colitis in patients with endoscopic mucosal healing
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 8 – Predicting remission & relapse (Keywords: endoscopic asessment, UC)
Authors: Kohei Yamakawa
DOP066: Disappearance of Anti-drug Antibodies to Infliximab and Adalimumab after Addition of an Immunomodulator in Patients with Inflammatory Bowel Disease
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 8 - Pharmacokinetics of IBD therapies (Keywords: adalimumab, anti-TNF, IBD, immunosuppresive agents, infliximab, methotrexate, trough levels)
Authors: Anne Strik
DOP066: Impaired mucosal permeability underlies ongoing irritable bowel syndrome-like symptoms, in patients with Inflammatory Bowel Disease who have achieved mucosal healing
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 8 - Predicting remission & relapse (Keywords: adalimumab, biologic treatment,clinical trials, disease oucome,ECCO, endoscopic asessment, IBD, CD, UC, immunosuppressive agents, infliximab, monitoring, intestinal permeability)
Authors: Rupert Leong